Algeness logo on a wall
Application areas algeness products
Advanced Aesthetic Technologies logo

A natural & safe youth for you

Doug Abel. President and CEO

Doug Abel.

  President and CEO

Advanced Aesthetic Technologies Inc. (AAT) is an USA based company developing bio-technologies in the aesthetic medical field. We are driven by the continuous pursuit of quality and excellence. Algeness® is the culmination of 10 years of scientific and clinical research and is intended for physicians and aesthetic patients seeking an efficient, high quality and safe filler. AAT’s Algeness® is an exceptional 100% natural and biodegradable filler with a unique injection technique enabling aesthetic physicians to truly Master their results.

A fast growing international development

A fast growing international development

LAT AMERICA

  • Bolivia
  • Chile
  • Colombia
  • Dominican Republic
  • Ecuador
  • Guatemala
  • Mexico
  • Paraguay
  • Peru

EUROPE

  • Azerbaijan
  • Bulgaria
  • Croatia
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Greece
  • Georgia
  • Iceland
  • Italy
  • Kazakhstan
  • Netherland
  • Norway
  • Poland
  • Portugal
  • Romania
  • Russia
  • Spain
  • Switzerland
  • Sweden
  • Turkey
  • Ukraine

MIDDLE EAST

  • Egypt
  • Iran
  • Iraq
  • Jordan
  • Lebanon
  • Saudi Arabia
  • UAE

ASIA

  • Hong Kong
  • China
  • Japan
  • Indonesia
  • Malaysia
  • Philippines
  • Korea
  • Thailand
  • Singapore

Board of directors and Executive team

Doug ABEL President and CEO
Doug ABEL
President and CEO
Peter Rogal Chairman of the board
Peter Rogal
Chairman of the board
John W. Cammett Founding Partner & CEO Aeroterm
John W. Cammett
Founding Partner & CEO Aeroterm
Mitchel Sayare Director of Boston IVF
Mitchel Sayare
Director of Boston IVF
Brian Kinney Plastic Surgeon
Brian Kinney
Plastic Surgeon
Brian Tinkham Member of the Board of Directors
Brian Tinkham
Member of the Board of Directors
Dr Wu Qiang Member of the Board of Directors
Dr Wu Qiang
Member of the Board of Directors

Our website uses cookies by continuing we assume your permission to use cookies as detailed in our cookies legal notice.